title: Gene therapy for erectile dysfunction: what is the future?
abstract: Gene transfer for the treatment of erectile dysfunction has completed phase 1 safety testing and has shown the necessary safety to proceed to the next level of clinical trial. This review focuses on the background of the components of that have led to US Food and Drug Administration acceptance of human gene transfer trials for nonlethal disease.
authors.affiliation: Department of Urology, Albert Einstein College of Medicine, New York, NY 10461, USA. arnold.melman@einstein.yu.edu
authors.forename: Arnold
authors.initials: A
authors.lastname: Melman
authors.forename: Kelvin
authors.initials: K
authors.lastname: Davies
mesh_terms: D000818:Animals; D007172:Erectile Dysfunction / Q000628:therapy*; D005544:Forecasting; D015316:Genetic Therapy / Q000639:trends*; D006801:Humans; D008297:Male